TickerFactsScreenerDevelopers

Altimmune, Inc. (ALT) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2010: $374.6K2011: $71.4K2013: $84.6K2014: $92.3K2015: $86.5K2016: $125.0K2017: $112.4K2018: $975.4K2019: $1.2K2020: $204.0K2021: $12.12M2022: $126.0K2023: $47.0K2025: $11.0K$11.0K
2010Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$11.0K—
2023$47.0K-62.7%
2022$126.0K-99.0%
2021$12.12M+5841.0%
2020$204.0K+16522.4%
2019$1.2K-99.9%
2018$975.4K+767.5%
2017$112.4K-10.0%
2016$125.0K+44.4%
2015$86.5K-6.2%
2014$92.3K+9.1%
2013$84.6K—
2011$71.4K-80.9%
2010$374.6K—